dc.contributor.author
Afshar-Bakshloo, Melissa
dc.contributor.author
Albers, Sarah
dc.contributor.author
Richter, Chiara
dc.contributor.author
Berninger, Ottilia
dc.contributor.author
Blohmer, Jens-Uwe
dc.contributor.author
Roehle, Robert
dc.contributor.author
Speiser, Dorothee
dc.contributor.author
Karsten, Maria Margarete
dc.date.accessioned
2025-09-03T09:55:29Z
dc.date.available
2025-09-03T09:55:29Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/49063
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-48786
dc.description.abstract
Background In breast cancer patients body image (BI) is a crucial aspect of quality of life (QoL). This study examined the postoperative impact of different surgical approaches on long-term BI analyzing real-world data to guide pre- and postoperative patient care and preserve QoL. Methods EORTC QLQ-BR23 BI scores were collected electronically in 325 breast cancer patients within routine clinical care for a duration of 41.5 months (11/17/2016 - 4/30/2020) at predefined time points preoperatively and repeatedly up to two years after breast-conserving surgery (BCS) (n = 212), mastectomy alone (M) (n = 27) or mastectomy with immediate breast reconstruction (MIBR) (n = 86). Higher scores indicated better BI. A linear mixed regression model was used to analyze the impact of BCS, M and MIBR, as well as non-surgical therapies on BI at treatment initiation and over time. Results BI scores deteriorated by 5 points (95%-confidence interval (CI) -8.94 to -1.57, p & AP;0.005) immediately after BCS, by 7 points (95%-CI -12.13 to -1.80, p & AP;0.008) after MIBR and by 19 points (95%-CI -27.34 to -10.34, p < 0.001) after M. The change over time after BCS (+ 0.10 points per week, 95%-CI -0.17 to 0.38), MIBR (-0.07 points per week, 95%-CI -0.35 to 0.20) and M (+ 0.14 points per week, 95%-CI -0.19 to 0.48) were not statistically significant (each p > 0.05). At treatment initiation chemotherapy was associated with a 22-point decline (95%-CI -25.39 to -17.87, p < 0.001) in BI score, while radiotherapy was associated with a 5-point increase (95%-CI 1.74 to 9.02, p & AP;0.004). However, over time chemotherapy was associated with a score recovery (+ 0.28 points per week, 95%-CI 0.19 to 0.37, p < 0.001), whereas for radiotherapy a trend towards BI deterioration was observed (-0.11 points per week, 95%-CI -0.23 to 0.02, p & AP;0.101). Conclusions Breast cancer surgery negatively affects BI. BCS and MIBR presumably harm BI less than M in the early postoperative period. Our data suggests BI to be deteriorating in the long term after MIBR while improving after BCS or M. Radiotherapy seems to have an additional negative long-term impact on BI. These findings should be confirmed in further studies to enable evidence-based patient information as part of preoperative shared decision-making and postoperative patient care.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
real-world data
en
dc.subject
breast cancer
en
dc.subject
patient-reported outcomes
en
dc.subject
breast-conserving surgery
en
dc.subject
immediate breast reconstruction
en
dc.subject
chemotherapy
en
dc.subject
radiotherapy
en
dc.subject
endocrine therapy
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
How breast cancer therapies impact body image – real-world data from a prospective cohort study collecting patient-reported outcomes
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
705
dcterms.bibliographicCitation.doi
10.1186/s12885-023-11172-y
dcterms.bibliographicCitation.journaltitle
BMC Cancer
dcterms.bibliographicCitation.number
1
dcterms.bibliographicCitation.originalpublishername
Springer Nature
dcterms.bibliographicCitation.volume
23
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
Springer Nature DEAL
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
37507687
dcterms.isPartOf.eissn
1471-2407